Latest news
Scholar Rock Holding Corporation (SRRK) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Sat, 08 Aug 2026 12:51:20 GMTScholar Rock drops Novo Nordisk facility from marketing application for muscle weakness drug - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 21:29:19 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:20:00 GMTScholar Rock Holdings Pulls Novo Nordisk Facility From Drug Application After FDA Flag -- Update - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 20:10:00 GMTScholar Rock Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:04:04 GMTSRRK SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Fri, 07 Aug 2026 10:44:11 GMTScholar Rock (NASDAQ:SRRK) Releases Earnings Results, Meets Estimates - MarketBeatMarketBeat · Fri, 07 Aug 2026 03:33:27 GMTThe Bull Case For Scholar Rock (SRRK) Could Change Following Dual-Track Apitegromab BLA Manufacturing Strategy - simplywall.stsimplywall.st · Thu, 06 Aug 2026 21:57:56 GMT